June 9, 2020
Bayer Yakuhin has already submitted its hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor molidustat in Japan in the first quarter of this year (January-March), a company spokesperson told Jiho on June 8. The submission was supported by results from the Japan...read more